Works by Hwang, Thomas J.
Results: 45
Regulatory Review Duration and Differences in Submission Times of Drugs in the United States and Europe, 2011 to 2020.
- Published in:
- Annals of Internal Medicine, 2023, v. 176, n. 10, p. 1413, doi. 10.7326/M23-0623
- By:
- Publication type:
- Article
Delays in completion and results reporting of clinical trials under the Paediatric Regulation in the European Union: A cohort study.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Therapeutic Value of Drugs Frequently Marketed Using Direct-to-Consumer Television Advertising, 2015 to 2021.
- Published in:
- JAMA Network Open, 2023, v. 6, n. 1, p. e2250991, doi. 10.1001/jamanetworkopen.2022.50991
- By:
- Publication type:
- Article
Therapeutic Value Assessments of Novel Medicines in the US and Europe, 2018-2019.
- Published in:
- JAMA Network Open, 2022, v. 5, n. 4, p. e226479, doi. 10.1001/jamanetworkopen.2022.6479
- By:
- Publication type:
- Article
Surgical Applications of 3-Dimensional Printing and PrecisionMedicine.
- Published in:
- JAMA Otolaryngology-Head & Neck Surgery, 2015, v. 141, n. 4, p. 305, doi. 10.1001/jamaoto.2015.44
- By:
- Publication type:
- Article
Retinal implants and Medicare reimbursement policies for breakthrough treatments in ophthalmology.
- Published in:
- 2015
- By:
- Publication type:
- journal article
Retinal Implants and Medicare Reimbursement Policies for Breakthrough Treatments in Ophthalmology.
- Published in:
- JAMA Ophthalmology, 2015, v. 133, n. 4, p. 373, doi. 10.1001/jamaophthalmol.2015.54
- By:
- Publication type:
- Article
Association between fluoroquinolone resistance and resistance to other antimicrobial agents among Escherichia coli urinary isolates in the outpatient setting: a national cross-sectional study.
- Published in:
- 2014
- By:
- Publication type:
- Journal Article
Association between fluoroquinolone resistance and resistance to other antimicrobial agents among Escherichia coli urinary isolates in the outpatient setting: a national cross-sectional study.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2014, v. 69, n. 6, p. 1720, doi. 10.1093/jac/dku029
- By:
- Publication type:
- Article
Valuing Patient Satisfaction: A New Paradigm in Medicare Hospital Reimbursement Policy.
- Published in:
- Harvard Health Policy Review, 2012, v. 13, n. 2, p. 40
- By:
- Publication type:
- Article
High-risk Therapeutic Devices Approved by the US Food and Drug Administration for Use in Children and Adolescents From 2016 to 2021.
- Published in:
- JAMA Pediatrics, 2023, v. 177, n. 1, p. 98, doi. 10.1001/jamapediatrics.2022.4131
- By:
- Publication type:
- Article
Inclusion of Children in Clinical Trials of Treatments for Coronavirus Disease 2019 (COVID-19).
- Published in:
- 2020
- By:
- Publication type:
- Opinion
Completion Rate and Reporting of Mandatory Pediatric Postmarketing Studies Under the US Pediatric Research Equity Act.
- Published in:
- JAMA Pediatrics, 2019, v. 173, n. 1, p. 68, doi. 10.1001/jamapediatrics.2018.3416
- By:
- Publication type:
- Article
Improving the Study of New Medicines for Children With Rare Diseases.
- Published in:
- JAMA Pediatrics, 2018, v. 172, n. 1, p. 8, doi. 10.1001/jamapediatrics.2017.4012
- By:
- Publication type:
- Article
New Regulatory Paradigms for Innovative Drugs to Treat Pediatric Diseases.
- Published in:
- JAMA Pediatrics, 2014, v. 168, n. 10, p. 879, doi. 10.1001/jamapediatrics.2014.904
- By:
- Publication type:
- Article
Paying for Prescription Drugs in the New Administration.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Lifecycle Regulation of Artificial Intelligence- and Machine Learning-Based Software Devices in Medicine.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Price Increases of Protected-Class Drugs in Medicare Part D, Relative to Inflation, 2012-2017.
- Published in:
- 2019
- By:
- Publication type:
- journal article
The FDA's Expedited Programs and Clinical Development Times for Novel Therapeutics, 2012-2016.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Value-Based Pricing and State Reform of Prescription Drug Costs.
- Published in:
- 2017
- By:
- Publication type:
- journal article
The Pediatric Research Equity Act Moves Into Adolescence.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Clinical benefit and cost of breakthrough cancer drugs approved by the US Food and Drug Administration.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Coverage of New Drugs in Medicare Part D.
- Published in:
- Milbank Quarterly, 2022, v. 100, n. 2, p. 562, doi. 10.1111/1468-0009.12565
- By:
- Publication type:
- Article
Pediatric Trials for Cancer Therapies With Targets Potentially Relevant to Pediatric Cancers.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Public Participation in Drafting of the 21st Century Cures Act.
- Published in:
- Journal of Law, Medicine & Ethics, 2017, v. 45, n. 2, p. 212, doi. 10.1177/1073110517720650
- By:
- Publication type:
- Article
New Treatments for Migraine-Therapeutic Ratings and Comparative Coverage in the US, Canada, and Europe.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Analysis of Proposed Medicare Part B to Part D Shift With Associated Changes in Total Spending and Patient Cost-Sharing for Prescription Drugs.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Failure of Investigational Drugs in Late-Stage Clinical Development and Publication of Trial Results.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Paying for innovation: Reimbursement incentives for antibiotics.
- Published in:
- Science Translational Medicine, 2015, v. 7, n. 276, p. 1, doi. 10.1126/scitranslmed.aaa1429
- By:
- Publication type:
- Article
Breakthrough Medical Devices and the 21st Century Cures Act.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Global Financing and Long-Term Technical Assistance for Multidrug-Resistant Tuberculosis: Scaling Up Access to Treatment.
- Published in:
- PLoS Medicine, 2014, v. 11, n. 9, p. 1, doi. 10.1371/journal.pmed.1001738
- By:
- Publication type:
- Article
Life Cycle of Medical Product Rules Issued by the US Food and Drug Administration.
- Published in:
- Journal of Health Politics, Policy & Law, 2014, v. 39, n. 4, p. 751, doi. 10.1215/03616878-2743027
- By:
- Publication type:
- Article
Association between progression‐free survival and patients' quality of life in cancer clinical trials.
- Published in:
- International Journal of Cancer, 2019, v. 144, n. 7, p. 1746, doi. 10.1002/ijc.31957
- By:
- Publication type:
- Article
Leveraging Novel and Existing Pathways to Approve New Therapeutics to Treat Serious Drug-Resistant Infections.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Estimates of Medicaid and Non-Medicaid Net Prices of Top-Selling Brand-name Drugs Incorporating Best Price Rebates, 2015 to 2019.
- Published in:
- JAMA Health Forum, 2023, v. 4, n. 1, p. e225012, doi. 10.1001/jamahealthforum.2022.5012
- By:
- Publication type:
- Article
Therapeutic Value of Drugs Granted Accelerated Approval or Conditional Marketing Authorization in the US and Europe From 2007 to 2021.
- Published in:
- JAMA Health Forum, 2022, v. 3, n. 8, p. e222685, doi. 10.1001/jamahealthforum.2022.2685
- By:
- Publication type:
- Article
Testing of New Drugs Approved From 2015 Through 2021 Under the US Pediatric Research Equity Act.
- Published in:
- JAMA: Journal of the American Medical Association, 2024, v. 332, n. 17, p. 1482, doi. 10.1001/jama.2024.18338
- By:
- Publication type:
- Article
Reforming the World Health Organization's Essential Medicines List: Essential but Unaffordable.
- Published in:
- 2022
- By:
- Publication type:
- journal article
New Reforms to Prescription Drug Pricing in the US: Opportunities and Challenges.
- Published in:
- JAMA: Journal of the American Medical Association, 2022, v. 328, n. 11, p. 1041, doi. 10.1001/jama.2022.15268
- By:
- Publication type:
- Article
Stock Market Returns and Clinical Trial Results of Investigational Compounds: An Event Study Analysis of Large Biopharmaceutical Companies.
- Published in:
- PLoS ONE, 2013, v. 8, n. 8, p. 1, doi. 10.1371/journal.pone.0071966
- By:
- Publication type:
- Article
Pre-market development times for biologic versus small-molecule drugs.
- Published in:
- 2019
- By:
- Publication type:
- Letter
Accelerating innovation in rapid diagnostics and targeted antibacterials.
- Published in:
- Nature Biotechnology, 2015, v. 33, n. 6, p. 589, doi. 10.1038/nbt.3251
- By:
- Publication type:
- Article
Precision medicine and the FDA's draft guidance on laboratory-developed tests.
- Published in:
- Nature Biotechnology, 2015, v. 33, n. 5, p. 449, doi. 10.1038/nbt.3221
- By:
- Publication type:
- Article
Medicaid Expenditures and Estimated Rebates on Line Extension Drugs, 2010-2018.
- Published in:
- 2022
- By:
- Publication type:
- Letter
European Medicines Agency's Priority Medicines Scheme at 2 Years: An Evaluation of Clinical Studies Supporting Eligible Drugs.
- Published in:
- Clinical Pharmacology & Therapeutics, 2020, v. 107, n. 3, p. 541, doi. 10.1002/cpt.1669
- By:
- Publication type:
- Article